Drug
C21
C21 is a pharmaceutical drug with 7 clinical trials. Historical success rate of 100.0%.
Total Trials
7
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 7 completed trials
Completion Rate
100%(7/7)
Active Trials
0(0%)
Results Posted
86%(6 trials)
Phase Distribution
Ph phase_2
3
43%
Ph phase_3
1
14%
Ph phase_1
2
29%
Phase Distribution
2
Early Stage
3
Mid Stage
1
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 2Efficacy & side effects
3(50.0%)
Phase 3Large-scale testing
1(16.7%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
7 of 7 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
7
all time
Status Distribution
Completed(7)
Detailed Status
Completed7
Development Timeline
Analytics
Development Status
Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 12 (33.3%)
Phase 23 (50.0%)
Phase 31 (16.7%)
Trials by Status
completed7100%
Recent Activity
0 active trials
Showing 5 of 7
completedphase_2
Safety, Efficacy and Pharmacokinetics of C21 in Subjects With IPF
NCT04533022
completedphase_1
Effect of C21 on Forearm Blood Flow
NCT05277922
completedphase_1
A Trial to Evaluate the Effect of C21 on Endothelial Dysfunction in Subjects With Type 2 Diabetes
NCT05831644
completed
Retrospective Evaluation of Lung Pathology in Subjects With COVID-19
NCT04878913
completedphase_3
A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects
NCT04880642
Clinical Trials (7)
Showing 7 of 7 trials
NCT04533022Phase 2
Safety, Efficacy and Pharmacokinetics of C21 in Subjects With IPF
NCT05277922Phase 1
Effect of C21 on Forearm Blood Flow
NCT05831644Phase 1
A Trial to Evaluate the Effect of C21 on Endothelial Dysfunction in Subjects With Type 2 Diabetes
NCT04878913
Retrospective Evaluation of Lung Pathology in Subjects With COVID-19
NCT04880642Phase 3
A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects
NCT04388176Phase 2
Cold Challenge With C21 in RP
NCT04452435Phase 2
Safety and Efficacy of C21 in Subjects With COVID-19
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7